Ileana L. Piña

Q: What Schools Are Affiliated With Ileana L. Piña

Ileana L. Piña is affiliated with the following schools: Yale University, Albert Einstein College of Medicine, University of Louisville, Wayne State University, Case Western Reserve University, RWTH Aachen University, Central Michigan University, Thomas Jefferson University

Ileana L. Piña's AcademicInfluence.com Rankings

Ileana L. Piña

Medical

#2124

World Rank

#2524

Historical Rank

Cardiology

#186

World Rank

#191

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Ileana L. Piña Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ileana L. Piña's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Ph (2003) (2115)
Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association (2013) (2088)
Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. (2001) (1948)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. (2020) (1835)
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. (2009) (1771)
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. (2011) (1730)
Statement on exercise. Benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart association. (1992) (1282)
Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. (2002) (1096)
Empagliflozin in Heart Failure with a Preserved Ejection Fraction. (2021) (1081)
Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. (2003) (979)
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness (2005) (966)
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. (2011) (895)
Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2014) (733)
Acute Heart Failure Syndromes: Current State and Framework for Future Research (2005) (731)
Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. (2009) (679)
Core components of cardiac rehabilitation/secondary prevention programs: A statement for healthcare professionals from the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation Writing Group. (2000) (533)
Statement on exercise: benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. (1996) (531)
AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endo (2000) (512)
Lower Serum Sodium Is Associated With Increased Short-Term Mortality in Hospitalized Patients With Worsening Heart Failure: Results From the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Study (2005) (469)
ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society (2005) (432)
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect A Scientific Statement From the American Heart Association (2018) (385)
Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction. (2019) (357)
Hospital Strategies Associated With 30-Day Readmission Rates for Patients With Heart Failure (2013) (354)
Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial (2017) (343)
Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. (2007) (336)
Assessment of functional capacity in clinical and research applications: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. (2000) (321)
Resistance Exercise in Individuals With and Without Cardiovascular Disease Benefits, Rationale, Safety, and Prescription An Advisory From the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association (2000) (320)
The Importance of Cardiorespiratory Fitness in the United States: The Need for a National Registry A Policy Statement From the American Heart Association (2013) (310)
ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-El (2006) (282)
Admission or Changes in Renal Function During Hospitalization for Worsening Heart Failure Predict Postdischarge Survival: Results From the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) (2008) (280)
AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services. (2007) (265)
Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines Program. (2009) (265)
Recommendations for Clinical Exercise Laboratories: A Scientific Statement From the American Heart Association (2009) (263)
Increasing Diversity in Clinical Trials: Overcoming Critical Barriers. (2019) (261)
Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. (2008) (245)
Status of Cardiovascular Disease and Stroke in Hispanics/Latinos in the United States: A Science Advisory From the American Heart Association (2014) (245)
Sex Differences in Clinical Characteristics and Prognosis in a Broad Spectrum of Patients With Heart Failure: Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Program (2007) (239)
Valsartan in acute myocardial infarction trial. (2004) (234)
Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. (2007) (229)
Patient Selection for Cardiac Resynchronization Therapy: From the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Heart Rhythm Society (2005) (229)
Exercise Standards for Testing and Training (2001) (228)
Metoprolol CR/XL in Female Patients With Heart Failure: Analysis of the Experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF) (2002) (216)
Galectin-3 in Ambulatory Patients With Heart Failure: Results From the HF-ACTION Study (2012) (209)
AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services endorsed by the American College of Chest Physicians, American College of Sports Medicine, American Physical Therapy Association, Canadian Associati (2007) (206)
Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. (2006) (193)
Clinical implications of chronic heart failure phenotypes defined by cluster analysis. (2014) (192)
Guidelines for clinical exercise testing laboratories. A statement for healthcare professionals from the Committee on Exercise and Cardiac Rehabilitation, American Heart Association. (1995) (189)
Heart failure in women: a need for prospective data. (2009) (189)
The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. (2013) (187)
Core Components of Cardiac Rehabilitation/Secondary Prevention Programs: Statement for Healthcare Professionals From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation (2000) (186)
Factors Related to Morbidity and Mortality in Patients With Chronic Heart Failure With Systolic Dysfunction: The HF-ACTION Predictive Risk Score Model (2012) (186)
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document (2013) (183)
Sex differences in heart failure (2018) (177)
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. (2019) (177)
ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-El (2006) (175)
ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults with Nonvalvular Atrial Fibrillation or Atrial Flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Wr (2008) (174)
Evaluating quality of care for patients with heart failure. (2000) (171)
A controlled trial of cardiac rehabilitation in the home setting using electrocardiographic and voice transtelephonic monitoring. (2000) (170)
ACCF/AHA 2007 clinical competence statement on vascular imaging with computed tomography and magnetic resonance. A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. (2005) (169)
Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. (2010) (167)
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice. (2012) (163)
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America. (2019) (162)
Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data. (2014) (160)
Relation between volume of exercise and clinical outcomes in patients with heart failure. (2012) (160)
AACVPR/ACCF/AHA 2010 update: performance measures on cardiac rehabilitation for referral to cardiac rehabilitation/secondary prevention services: a report of the American Association of Cardiovascular and Pulmonary Rehabilitation and the American College of Cardiology Foundation/American Heart Assoc (2010) (157)
ACCF/AHA/AMA-PCPI 2011 Performance Measures for Adults With Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association–Physician Consortium for Performance Improvement (2012) (148)
Practical recommendations for the use of ACE inhibitors, beta‐blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice (2005) (144)
Variables Measured During Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure. (2016) (143)
Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes: Lessons Learned and Directions Forward (2010) (141)
Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS‐9) in heart failure patients: results from a phase 3 randomized, double‐blind, placebo‐controlled trial (2015) (137)
Exercise training as therapy for heart failure: current status and future directions. (2015) (134)
Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure. (2014) (124)
Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing). (2008) (124)
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure. (2014) (119)
Utility of Patient-Reported Outcome Instruments in Heart Failure. (2016) (118)
Soluble ST2 in Ambulatory Patients With Heart Failure: Association With Functional Capacity and Long-Term Outcomes (2013) (116)
ACC/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. (2008) (111)
Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials. (2014) (108)
Safety and utility of exercise testing in emergency room chest pain centers: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. (2000) (108)
The past, present and future of renin-angiotensin aldosterone system inhibition. (2013) (106)
Galectin-3 in Ambulatory Patients With Heart FailureClinical Perspective (2012) (106)
National Survey of Hospital Strategies to Reduce Heart Failure Readmissions: Findings From the Get With the Guidelines-Heart Failure Registry (2012) (103)
Exercise and heart failure. (2004) (101)
ACCF/AHA/SCAI 2013 Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures (2013) (97)
ACC/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. (2008) (92)
Hyperkalemia in Heart Failure. (2016) (90)
Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial. (2012) (89)
Measuring and improving quality of care: a report from the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke. (2000) (89)
A randomized clinical trial of the clinical effects of enhanced heart failure monitoring using a computer-based telephonic monitoring system in older minorities and women. (2007) (87)
The coalition to reduce racial and ethnic disparities in cardiovascular disease outcomes (credo): why credo matters to cardiologists. (2011) (85)
A randomized controlled trial of high dose vitamin D3 in patients with heart failure. (2013) (83)
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial (2021) (83)
Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION). (2013) (81)
Sex-specific mortality risk by QRS morphology and duration in patients receiving CRT: results from the NCDR. (2014) (81)
ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (writing Committee to Update the 199 (2007) (80)
Clinical Implications of the New York Heart Association Classification (2019) (79)
The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results. (2013) (79)
Measuring and improving quality of care : A report from the american heart Association/American college of cardiology first scientific forum on assessment of healthcare quality in cardiovascular disease and stroke (2000) (77)
ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. (2012) (77)
ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant: a report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training. (2010) (76)
Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure: Insights From the HF-ACTION Study. (2017) (75)
Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate‐lowering properties (2014) (71)
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR‐Preserved trial (2020) (70)
Heart failure management in skilled nursing facilities: a scientific statement from the American Heart Association and the Heart Failure Society of America. (2015) (69)
Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial. (2016) (68)
Outcomes, health policy, and managed care: relationships between patient-reported outcome measures and clinical measures in outpatients with heart failure. (2009) (67)
Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE‐HF) (2018) (66)
Psychopharmacology and Cardiovascular Disease. (2018) (66)
Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure. (2012) (65)
Clinical role of exercise training in the management of patients with chronic heart failure. (2010) (65)
Cardiac Resynchronization Therapy in Women Versus Men: Observational Comparative Effectiveness Study From the National Cardiovascular Data Registry (2015) (65)
Erratum: 'Evaluating quality of care for patients with heart failure' (Circulation (2000) 101 (e122-e140)) (2000) (63)
Pharmacodynamic effects of milrinone with and without a bolus loading infusion. (2001) (61)
AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services. (2007) (61)
Effects of exercise training on outcomes in women with heart failure: analysis of HF-ACTION (Heart Failure-A Controlled Trial Investigating Outcomes of Exercise TraiNing) by sex. (2014) (58)
Is it important to examine gender differences in the epidemiology and outcome of severe heart failure? (2004) (58)
World Heart Federation Roadmap for Heart Failure. (2019) (57)
Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial (2021) (56)
AACVPR/ACCF/AHA 2010 Update: Performance Measures on Cardiac Rehabilitation for Referral to Cardiac Rehabilitation/Secondary Prevention Services Endorsed by the American College of Chest Physicians, the American College of Sports Medicine, the American Physical Therapy Association, the Canadian Asso (2010) (56)
Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. (2009) (54)
The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure. (2014) (53)
Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry. (2009) (53)
Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial. (2020) (53)
Economic Evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) Randomized Controlled Trial: An Exercise Training Study of Patients With Chronic Heart Failure (2010) (52)
Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction (2020) (51)
Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association (2021) (51)
A framework for describing health care delivery organizations and systems. (2015) (51)
Care and Outcomes of Hispanic Patients Admitted With Heart Failure With Preserved or Reduced Ejection Fraction: Findings From Get With The Guidelines–Heart Failure (2012) (50)
Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice. (2001) (50)
Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel. (2021) (50)
AACVPR/ACCF/AHA 2010 Update: Performance measures on cardiac rehabilitation for referral to cardiac rehabilitation/secondary prevention services: A report of the American Association of Cardiovascular and Pulmonary Rehabilitation and the American College of Cardiology Foundation/American Heart Assoc (2010) (49)
Design of a multicenter randomized trial for the Stroke Prevention in Atrial Fibrillation Study. The Stroke Prevention in Atrial Fibrillation Investigators. (1990) (48)
Home Health Care With Telemonitoring Improves Health Status for Older Adults With Heart Failure (2013) (47)
Left bundle branch block predicts better survival in women than men receiving cardiac resynchronization therapy: long-term follow-up of ∼ 145,000 patients. (2012) (46)
Cost of medical services in older patients with heart failure: those receiving enhanced monitoring using a computer-based telephonic monitoring system compared with those in usual care: the Heart Failure Home Care trial. (2010) (46)
Frailty Assessment in Advanced Heart Failure. (2016) (46)
Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure. (2000) (46)
Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week. (2021) (45)
Prospective evaluation of the association between hemoglobin concentration and quality of life in patients with heart failure. (2009) (44)
The Bridge Project: improving heart failure care in skilled nursing facilities. (2012) (43)
Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America. (2019) (43)
Sleep symptoms and clinical markers of illness in patients with heart failure (2005) (43)
Psychosocial Factors, Exercise Adherence, and Outcomes in Heart Failure Patients: Insights From Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION). (2015) (43)
Baseline differences in the HF-ACTION trial by sex. (2009) (42)
Implementation of a Patient Navigator Program to Reduce 30-day Heart Failure Readmission Rate. (2017) (41)
Reprint-AACVPR/ACCF/AHA 2010 Update: Performance Measures on Cardiac Rehabilitation for Referral to Cardiac Rehabilitation/Secondary Prevention Services. (2010) (41)
Association between adrenergic receptor genotypes and beta‐blocker dose in heart failure patients: analysis from the HF‐ACTION DNA substudy (2013) (41)
Clinical trials of beta blockers for heart failure (2003) (39)
Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure). (2014) (39)
Representation of Women Authors in International Heart Failure Guidelines and Contemporary Clinical Trials (2020) (38)
Beta blocker dose and markers of sympathetic activation in heart failure patients: interrelationships and prognostic significance (2017) (37)
Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction. (2019) (37)
Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial. (2021) (37)
Variability in the clinical status of patients with advanced heart failure. (2004) (37)
Response to Exercise Training and Outcomes in Patients With Heart Failure and Diabetes Mellitus: Insights From the HF-ACTION Trial. (2016) (36)
Trials of implantable monitoring devices in heart failure: which design is optimal? (2014) (35)
ACCF/AHA/SCAI 2007 update of the Clinical Competence Statement on Cardiac Interventional Procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Update the 199 (2007) (35)
Comparison of four exercise protocols using anaerobic threshold measurement of functional capacity in congestive heart failure. (1990) (35)
ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant: a report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training. (2010) (35)
Intrinsic Conduction Maximizes Cardiopulmonary Performance in Patients with Dual Chamber Pacemakers (1991) (34)
N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study. (2009) (34)
Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction. (2020) (33)
Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure. (2018) (32)
Relationship between changing patient‐reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF‐ACTION (2018) (32)
Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION. (2014) (32)
The Safety of an Adenosine A1-Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment (2012) (31)
Beyond drug therapy: nonpharmacologic care of the patient with advanced heart failure. (1998) (31)
Anemia and Associated Clinical Outcomes in Patients With Heart Failure Due to Reduced Left Ventricular Systolic Function (2013) (30)
Socioeconomic and partner status in chronic heart failure: Relationship to exercise capacity, quality of life, and clinical outcomes (2017) (30)
Heart Failure Transitions of Care: A Pharmacist-Led Post-Discharge Pilot Experience. (2017) (30)
Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction—Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF‐ACTION)trial (2017) (30)
Evaluation of pulmonary hypertension in heart transplant candidates (2003) (30)
Differences in treatment patterns and outcomes between Hispanics and non-Hispanic Whites treated for ST-segment elevation myocardial infarction: results from the NCDR ACTION Registry-GWTG. (2012) (29)
CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial. (2019) (29)
Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events. (2015) (28)
Optimal candidates for heart transplantation: is 14 the magic number? (1995) (28)
Exercise and heart failure. A review. (1996) (28)
Race, exercise training, and outcomes in chronic heart failure: findings from Heart Failure - a Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION). (2013) (28)
ACCF/AHA 2007 clinical competence statement on vascular imaging with computed tomography and magnetic resonance: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training: developed in collaborat (2007) (27)
Sex Difference in Patients With Ischemic Heart Failure Undergoing Surgical Revascularization: Results From the STICH Trial (Surgical Treatment for Ischemic Heart Failure) (2018) (27)
Improving Heart Failure Disease Management in Skilled Nursing Facilities (2013) (27)
Clinical factors related to morbidity and mortality in high‐risk heart failure patients: the GUIDE‐IT predictive model and risk score (2019) (26)
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination. (2001) (26)
Temporal Trends and Factors Associated With Cardiac Rehabilitation Participation Among Medicare Beneficiaries With Heart Failure. (2021) (26)
Multinational and multiethnic variations in health‐related quality of life in patients with chronic heart failure (2017) (25)
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial (2022) (25)
Medication adherence: Importance, issues and policy: A policy statement from the American Heart Association. (2020) (24)
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology (2022) (24)
Exercise training and pacing status in patients with heart failure: results from HF-ACTION. (2015) (24)
A device is not a drug. (2003) (24)
Design Considerations for Clinical Trials of Autonomic Modulation Therapies Targeting Hypertension and Heart Failure (2015) (24)
Trends In Heart Failure Hospitalizations (2012) (24)
Role and benefits of exercise in the management of patients with heart failure (2010) (24)
Heart Failure in Women (2003) (23)
Patiromer for the management of hyperkalaemia in patients receiving renin–angiotensin–aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial (2021) (23)
Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial. (2014) (22)
Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan. (2020) (22)
Clinical and analytical considerations in the study of health status in device trials for heart failure. (2005) (22)
Current challenges for clinical trials of cardiovascular medical devices. (2014) (22)
Psychosocial Factors, Exercise Adherence, and Outcomes in Heart Failure PatientsCLINICAL PERSPECTIVE (2015) (22)
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HF. (2019) (21)
Are there negative responders to exercise training among heart failure patients? (2014) (21)
BNP-guided therapy for heart failure. (2009) (21)
Non-invasive assessment of low risk acute chest pain in the emergency department: A comparative meta-analysis of prospective studies. (2015) (21)
Donor Troponin and Survival After Cardiac Transplantation: An Analysis of the United Network of Organ Sharing Registry. (2016) (21)
A better survival for women with heart failure? It's not so simple ... (2003) (21)
Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes. (2020) (21)
Tolerability of extended duration intravenous milrinone in patients hospitalized for advanced heart failure and the usefulness of uptitration of oral angiotensin-converting enzyme inhibitors. (1999) (20)
Heart Failure Management in Skilled Nursing Facilities: A Scientific Statement From the American Heart Association and the Heart Failure Society of America (2015) (20)
Cardiovascular disease in women: challenge of the middle years. (2011) (20)
Predictors of motor tasks essential for daily activities among persons with heart failure. (2008) (20)
Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock. (2019) (20)
Hemodynamic and Neurohumoral Responses to Intravenous Nicorandil in Congestive Heart Failure in Humans (1992) (19)
Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure. (2018) (19)
Sex‐based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan (2020) (19)
Personalized medicine and Hispanic health: improving health outcomes and reducing health disparities – a National Heart, Lung, and Blood Institute workshop report (2017) (19)
Cardiac rehabilitation in older adults: New options (2019) (19)
Heart failure in women. (2003) (19)
Microvascular obstruction detected by cardiac MRI after AMI for the prediction of LV remodeling and MACE: A meta-analysis of prospective trials. (2016) (18)
Hypertension and Antihypertensive Therapy in Hispanics and Mexican Americans Living in the United States (2011) (18)
Biomarker-guided therapies in heart failure: a forum for unified strategies. (2013) (17)
Association Between Angiotensin Receptor–Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction (2021) (17)
Therapeutic role of angiotensin II receptor blockers in the treatment of heart failure. (2003) (17)
Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction. (2020) (16)
Aligning quality and payment for heart failure care: defining the challenges. (2003) (16)
Predictors of Cardiac Rehabilitation Initiation and Adherence in a Multiracial Urban Population (2017) (16)
Gender-related dissociation in outcomes in chronic heart failure: reduced mortality but similar hospitalization in women. (2011) (16)
The kansas city cardiomyopathy questionnaire is sensitive to clinical change in congestive heart failure (2002) (16)
Cardiac Rehabilitation in Heart Failure: A Brief Review and Recommendations (2010) (16)
Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF (2021) (16)
Proceedings from Duke resistant hypertension think tank. (2014) (16)
The potential role of natriuretic peptide-guided management for patients hospitalized for heart failure. (2015) (15)
Stress-Induced Cardiomyopathy. (2019) (15)
Regional differences in clinical profile, quality of care, and outcomes among Hispanic patients hospitalized with acute myocardial infarction in the Get with Guidelines-Coronary Artery Disease (GWTG-CAD) registry. (2011) (15)
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. (2021) (14)
From acute decompensated to chronic heart failure. (2014) (13)
A Randomized Controlled Trial of High-Dose Vitamin D 3 in Patients With Heart Failure (2013) (13)
National Survey of Hospital Strategies to Reduce Heart Failure ReadmissionsClinical Perspective (2012) (13)
2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference Report. (2021) (13)
Evaluation of an immunoradiometric assay specific for the CK-MB isoenzyme for detection of acute myocardial infarction. (1984) (12)
2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference Report. (2021) (12)
PredischaRge initiation of Ivabradine in the ManagEment of Heart Failure: Results of the PRIME-HF Trial. (2020) (11)
Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan (2020) (11)
Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials: A Call to Action From the Heart Failure Collaboratory. (2022) (11)
Research Priorities in the Secondary Prevention of Atrial Fibrillation: A National Heart, Lung, and Blood Institute Virtual Workshop Report (2021) (11)
Hemoglobin, exercise training, and health status in patients with chronic heart failure (from the HF-ACTION randomized controlled trial). (2013) (11)
Heart Failure Postdischarge Clinic: A Pharmacist-led Approach to Reduce Readmissions. (2019) (11)
Understanding heart failure with preserved ejection fraction: clinical importance and future outlook. (2009) (11)
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock. (2020) (11)
Statins and Exercise Training Response in Heart Failure Patients: Insights From HF-ACTION. (2016) (11)
Evaluation of the Incremental Prognostic Utility of Increasingly Complex Testing in Chronic Heart Failure (2015) (11)
Association of post-discharge specialty outpatient visits with readmissions and mortality in high-risk heart failure patients. (2019) (11)
Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized clinical trials (2018) (10)
Burden of medical co‐morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy (2019) (10)
Prognostic value of hyponatremia in hospitalized patients with worsening heart failure - insights from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME - CHF) (2003) (10)
Lead systems: sensitivity and specificity. (1984) (10)
Relation of Angina Pectoris to Outcomes, Quality of Life, and Response to Exercise Training in Patients With Chronic Heart Failure (from HF-ACTION). (2016) (10)
Scope of heart failure hospitalization. (2012) (10)
Frailty Status Modifies the Efficacy of Exercise Training Among Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the HF-ACTION Trial (2022) (9)
STAMINA-HFP (study of anemia in a heart failure population) registry: rationale, design, and patient characteristics (2003) (9)
Persistence of 123I-mIBG Prognostic Capability in Relation to Medical Therapy in Heart Failure (from the ADMIRE-HF Trial). (2017) (9)
Authorship in a multicenter clinical trial: The Heart Failure-A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) Authorship and Publication (HAP) scoring system results. (2015) (9)
Prognostic significance of depression in blacks with heart failure: insights from Heart Failure: a Controlled Trial Investigating Outcomes of Exercise Training. (2015) (9)
Medical Therapy During Hospitalization for Heart Failure with Reduced Ejection Fraction: The VICTORIA Registry: Medical Therapy During Hospitalization for HFrEF. (2022) (9)
Loop diuretic adjustments in patients with chronic heart failure: Insights from HF‐ACTION (2018) (8)
Atrial fibrillation inducibility during cavo-tricuspid isthmus dependent atrial flutter ablation for the prediction of clinical atrial fibrillation. (2017) (8)
Evaluation of the Heart Truth professional education campaign on provider knowledge of women and heart disease. (2013) (8)
Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency (2022) (8)
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction (2022) (8)
Treating female heart failure patients with metoprolol CR/XL (2002) (8)
Prognostic Significance of Depression in African Americans With Heart Failure: Insights from HF-ACTION (2015) (8)
842-5 Anemia is common in patients with heart failure seen in specialty and community cardiology clinics: Results from the STAMINA: HFP registry (study of anemia in a heart failure population) (2004) (7)
Longitudinal profile of NT-proBNP levels in ischemic heart failure patients undergoing surgical ventricular reconstruction: The Biomarker Plus study. (2018) (7)
Quality improvement in heart failure: a randomized educational intervention to change provider behavior. (2012) (7)
The American Heart Association Heart Failure Summit, Bethesda, April 12, 2017. (2018) (7)
Donor Troponin and Survival After Cardiac TransplantationCLINICAL PERSPECTIVE (2016) (7)
Transitions of Care in Heart Failure: The Case for Comparative Effectiveness Research (2011) (6)
Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction—Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF‐ACTION) randomized controlled trial (2018) (6)
EXERCISE TRAINING AND IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SHOCKS IN PATIENTS WITH HEART FAILURE: RESULTS FROM HF-ACTION (2010) (6)
Government continues to have an important role in promoting cardiovascular health (2018) (6)
Participation in a Heart Failure Clinical Trial (2021) (6)
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research (2022) (6)
A controlled trial of cardiac rehabilitation in the home setting: Improving accessibility (1996) (6)
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research (2022) (6)
Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2. (2020) (6)
Mechanical circulatory support devices for acute heart failure syndromes: considerations for clinical trial design (2008) (6)
Exercise test interpretation. (1993) (6)
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 4--treatment. (2002) (6)
From the American Heart Association Recommendations for Clinical Exercise Laboratories: A Scientific Statement (2009) (6)
Engaging Families in Adult Cardiovascular Care: A Scientific Statement From the American Heart Association (2022) (5)
Heart failure management throughout the continuum. (2020) (5)
Council on Clinical Cardiology, American Heart Association Advisory From the Committee on Exercise, Rehabilitation, and Prevention, Assessment of Functional Capacity in Clinical and Research Applications : An (2008) (5)
Health Literacy: An Important Clinical Tool in Heart Failure (2018) (5)
Recent advances in the diagnosis of fascicular blocks. (1987) (5)
BETA-1 ADRENERGIC RECEPTOR GENOTYPE SER49GLY IS ASSOCIATED WITH BETA-BLOCKER SURVIVAL BENEFIT IN PATIENTS WITH HEART FAILURE (2012) (5)
Improving Quality of Cardiac Care: A Global Mandate. (2015) (5)
Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction. (2022) (5)
Heart Failure Clinical Trial Operations During the COVID-19 Pandemic (2020) (5)
Risks and benefits of a multidrug approach to mild-to-moderate heart failure. (2001) (5)
Improving Provider Adherence to Guideline Recommendations in Heart Failure (2018) (5)
Sunday, 26 August 2012 (2012) (5)
Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the Week. (2021) (5)
Clinical parameters of adolescent Hispanic male hypertensive subjects: a new subject? (1987) (4)
Heart failure in ethnic minorities: slow and steady progress. (2014) (4)
Behavioral intervention, nutrition, and exercise trials in heart failure. (2011) (4)
The Impact of Mediators of Health Literacy on Clinical Outcomes in Cardiovascular Diseases. (2018) (4)
Effect of patiromer on serum potassium in hyperkalemic patients with heart failure: Pooled analysis of 3 randomized trials. (2020) (4)
Renal Function and Exercise Training in AmbulatoryHeart Failure Patients With a Reduced Ejection Fraction. (2018) (4)
Association between body surface area and prescribed doses of guideline‐directed medications among international patients with heart failure and reduced ejection fraction (2019) (4)
SEX-SPECIFIC MORTALITY RISK BY QRS MORPHOLOGY AND DURATION IN PATIENTS RECEIVING CARDIAC RESYNCHRONIZATION THERAPY: RESULTS FROM THE NCDR® (2014) (4)
Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart Failure (2021) (3)
Association of quality of life with improved clinical outcomes: results from the valsartan heart failure trial (2002) (3)
Lower Hemoglobin Is Associated with Persistently Reduced Quality of Life in Unselected Patients with Heart Failure: Results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry (2004) (3)
An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum (2022) (3)
Abstract 252: PredischaRge Initiation of Ivabradine in the ManagEment of Heart Failure: Results of the PRIME-HF Trial (2019) (3)
Managing the Economic Challenges in the Treatment of Heart Failure. (2018) (3)
Monday, 27 August 2012 (2012) (3)
Professionals From the American Heart Association / American Stroke Association Guidelines for the Prevention of Stroke in Women : A Statement for Healthcare (2014) (3)
Training trials in heart failure: time to exercise restraint? (2004) (3)
Committee on Exercise, Rehabilitation, and Prevention Exercise and Heart Failure: A Statement From the American Heart Association (2009) (3)
Home Telemonitoring Improves Health Status in the Post-Hospitalization Period for Patients With Heart Failure (2010) (3)
Disseminating QI interventions. (2007) (3)
Responder analysis for improvement in 6‐min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency (2022) (3)
Minimal Clinically Important Difference for Six-minute Walk Test in Patients with HFrEF and Iron Deficiency. (2022) (2)
Diastolic dysfunction and heart failure with preserved ejection fraction in women. (2011) (2)
From the American Heart Association Exercise Standards for Testing and Training : A Statement for Healthcare Professionals (2013) (2)
Abstract 17649: Elevated Galectin-3 Levels and Prediction of Mode of Death in Heart Failure: Insights from the HF-ACTION Study (2012) (2)
The influence of comorbidities on achieving an N‐terminal pro‐b‐type natriuretic peptide target: a secondary analysis of the GUIDE‐IT trial (2021) (2)
Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients with HFrEF: Results from the CONNECT-HF Trial. (2022) (2)
Key issues in trial design for ventricular assist devices: a position statement of the Heart Failure Society of America. (2004) (2)
American Heart Association's Call to Action for Payment and Delivery System Reform. (2017) (2)
Reprint--AACVPR/ACCF/AHA 2010 update: performance measures on cardiac rehabilitation for referral to cardiac rehabilitation/secondary prevention services: a report of the American Association of Cardiovascular and Pulmonary Rehabilitation and the American College of Cardiology Foundation/American He (2010) (2)
842-6 Anemia is associated with reduced health status measures in patients with heart failure: Results from the STAMINA: HFP (study of anemia in a heart failure population) registry (2004) (2)
If It Is Not Health Care Access or Insurance Coverage, Then Why Do Racial Disparities Persist? (2018) (2)
Abstract 11405: Non-Invasive Assessment of Chest Pain in the Emergency Department: A Meta-Analysis of Prospective Trials (2013) (2)
Clinical Pharmacology Education in a Division of Cardiology (1991) (2)
SGLT2 inhibitors: the story continues to unfold. (2021) (2)
The AHF SCENE II Preceptorship Program: rationale and design of an educational program to optimize management of advanced heart failure. (2000) (2)
Comprehensive Heart Failure Management. (2017) (2)
Managing the economic challenges in the treatment of heart failure (2021) (2)
Age Differences in Effects of Sacubitril/Valsartan on Cardiac Remodeling, Biomarkers, and Health Status. (2022) (2)
Low‐Dose Acebutolol Given Once Daily in the Treatment of Chronic Angina Pectoris (1988) (2)
EXERCISE CAPACITY AND MORTALITY IN PATIENTS WITH ISCHEMIC LEFT VENTRICULAR DYSFUNCTION RANDOMIZED TO CORONARY ARTERY BYPASS SURGERY OR MEDICAL THERAPY: AN ANALYSIS FROM THE SURGICAL TREATMENT FOR ISCHEMIC HEART FAILURE TRIAL (2014) (2)
Gender differences in heart failure clinical characteristics and therapy: Report from UNITE-HF Multicenter Heart Failure Database (2001) (2)
Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction: findings from the HF-ACTION trial. (2022) (2)
Research Acute Heart Failure Syndromes: Current State and Framework for Future (2006) (2)
Differences in NT‐proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction (2021) (2)
Effect of Natriuretic Peptide-Guided Therapy on Outcomes in High-Risk Patients with Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial (2017) (2)
Stroke prevention using an oral thrombin inhibitor in atrial fibrillation. (2004) (2)
Heart failure in Hispanic patients: coming together? (2010) (2)
Myocardial Infarction after Endoscopic Removal of Foreign Body (2017) (2)
Prognosis and mechanism of death in treated heart failure: data from the placebo arm of Val-HeFT. (2006) (2)
Cardiac rehabilitation for patients with ventricular assist devices an offer to improve strong collaborative relationships. (2010) (2)
Do PRO measures function the same way for all individuals with heart failure? (2022) (2)
Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale (2003) (2)
Disparities in Women with Heart Failure (2011) (2)
Advanced heart failure SCENE: An innovative approach to clinical education (1996) (2)
Effects of Angiotensin Receptor/Neprilysin Inhibitor Therapy on Amino-terminal Pro-B-Type Natriuretic Peptide and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction: The PROVE-HF Study (2019) (2)
General Principles, Clinical Definition, Epidemiology, and Pathophysiology (2021) (1)
SLEEP-DISORDERED BREATHING, CARDIAC BIOMARKERS AND SLEEPINESS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (2014) (1)
Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction: findings from the HF-ACTION trial. (2022) (1)
Enhanced external counterpulsation: what can we learn from the treatment of neurasthenia? (2006) (1)
Effects of encainide and metabolizer phenotype on ventricular conduction during exercise. (1990) (1)
INTRAVENOUS DILTIAZEM, AS COMPARED TO INTRAVENOUS METOPROLOL, FOR ATRIAL FIBRILLATION/FLUTTER IS ASSOCIATED WITH INCREASED ADMISSION FROM THE EMERGENCY DEPARTMENT (2016) (1)
Exercise-induced coronary artery spasm after percutaneous transluminal angioplasty. (1988) (1)
Investigating gender-based differential item functioning on the Kansas City Cardiomyopathy Questionnaire (KCCQ) using qualitative content analysis (2022) (1)
DETERMINANTS OF MORBIDITY AND MORTALITY IN CHRONIC HEART FAILURE (CHF) WITH SYSTOLIC DYSFUNCTION: RESULTS OF THE HF-ACTION PREDICTIVE MODEL (2010) (1)
Nutrition, and Exercise Trials in Heart Failure (2011) (1)
How Long Will We Play the Ostrich Game? (2020) (1)
Beta-Blocker Selectivity in Heart Failure (HF) Patients With Chronic Obstructive Pulmonary Disease (COPD): Insights from HF-A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) (2012) (1)
Policy and Payment Challenges in the Postpandemic Treatment of Heart Failure: Value-Based Care and Telehealth (2021) (1)
SOCIOECONOMIC STATUS, MARITAL STATUS AND OUTCOMES IN HEART FAILURE: FINDINGS FROM HF-ACTION (2014) (1)
Abstract 17587: Implications of Angina Pectoris on Quality of Life, Functional Capacity and Clinical Outcomes in Chronic Heart Failure Patients: Insights From HF-ACTION (2015) (1)
National Registry : A Policy Statement From the American Heart Association The Importance of Cardiorespiratory Fitness in the United States: The Need for a (2013) (1)
A view of preserved systolic function and the approach to the heart failure patient. (2005) (1)
Beta-blocker and ACE-inhibitor Dosing as a Function of Body Surface Area: From the HF-ACTION trial. (2020) (1)
Heart Failure Duration and Mechanistic Efficacy of Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction. (2022) (1)
Circulating Angiokines are Associated with Reverse Remodeling and Outcomes in Chronic Heart Failure. (2023) (1)
REGIONAL DIFFERENCES IN CLINICAL PROFILE, QUALITY OF CARE AND OUTCOMES AMONG HISPANIC PATIENTS HOSPITALIZED WITH ACUTE MYOCARDIAL INFARCTION IN THE GET WITH GUIDELINES-CORONARY ARTERY DISEASE REGISTRY (2011) (1)
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved (2022) (1)
Exercise testing and training in heart failure (2005) (1)
Association Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Rationale, Safety, and PrescriptionAn Advisory From the Committee on Exercise, Resistance Exercise in Individuals With and Without Cardiovascular Disease : Benefits, (2012) (1)
Comparative Effect of Angiotensin Receptor Neprilysin Inhibition on B-type Natriuretic Peptide Levels Measured by Three Different Assays: The PROVE-HF Study. (2022) (1)
Primary role of B-type natriuretic peptide across the clinical spectrum: from emergency medicine to transitional care and beyond into the community. (2011) (1)
Prediction of Left Ventricular Ejection Fraction Change Following Treatment With Sacubitril/Valsartan. (2022) (1)
Erratum: Variables Measured during Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure (Journal of the American College of Cardiology (2016) 67 (780-789)) (2016) (1)
Corrigendum to "Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America" Journal of Cardiac Failure Vol. 25 No. 8, pp. 584-619. (2019) (1)
AEROBIC EXERCISE TRAINING AND HEALTH STATUS IN AMBULATORY HEART FAILURE PATIENTS WITH A REDUCED EJECTION FRACTION: AN ANALYSIS FROM THE HF-ACTION TRIAL (2016) (1)
Bushnell et al Guidelines for Prevention of Stroke in Women 1547 Incidence Ischemic Stroke (2014) (1)
Effect Of Vericiguat In Victoria According To Guideline-directed Medical Therapy (2020) (1)
Personalized medicine and Hispanic health: Improving health outcomes and reducing health disparities (2017) (1)
The Pivotal Role of Women in Cardiology Sections in Medical Organizations: From Leadership Training to Personal Enrichment (2021) (1)
Changes in Resting and Maximal Exercise Heart Rate during Dosing of Beta Blocker Therapy in Patients with Systolic Heart Failure (2008) (1)
RESPONSE TO EXERCISE TRAINING AND OUTCOMES IN HEART FAILURE PATIENTS WITH DIABETES MELLITUS: INSIGHTS FROM HF-ACTION (2015) (1)
ELDERLY PATIENTS ARE LESS LIKELY TO RECEIVE EVIDENCE-BASED MEDICATIONS INDICATED FOR SYSTOLIC HEART FAILURE: RESULTS FROM THE STUDY OF ANEMIA IN A HEART FAILURE POPULATION (STAMINA-HFP) REGISTRY (2010) (1)
RATIONALE AND METHODS OF THE PROSPECTIVE STUDY OF BIOMARKERS, SYMPTOM IMPROVEMENT AND VENTRICULAR REMODELING DURING ENTRESTO THERAPY FOR HEART FAILURE (PROVE-HF) STUDY (2017) (1)
Physical activity needs to be a lifelong commitment. (2003) (1)
High Prevalence of Frailty and Cognitive Impairment in Non-Elderly Heart Failure Patients (2016) (1)
Hostile Work Environment: A Case of the Emperor's New Clothes. (2021) (1)
Clinical Cardiac Rehabilitation: A Cardiologist's Guide (1996) (1)
Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study (2022) (1)
Sex Differences in Heart Failure—Female Representation in Heart Failure Studies (2019) (1)
Heart Failure Management and Development of Heart Failure Programs (2017) (0)
Adherence to Heart Failure Performance Measures: Self-Assessment in a Heart Failure Specialty Clinic (2006) (0)
WHAT IS THE VALUE OF REPEATED NT-PROBNP MEASUREMENTS IN CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION? (2023) (0)
Clinical trials report (2005) (0)
Therapy for systolic heart failure. (2004) (0)
Two year follow-up of the functional and morphologic adaptation of undersized donor hearts following cardiac transplantation (1996) (0)
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research (2022) (0)
Relationship between Galectin-3 Levels and Mineralocorticoid Receptor Antagonist Use in Heart Failure: Analysis from the HF- ACTION Study (2014) (0)
HEALTH RELATED QUALITY OF LIFE AND FUNCTIONAL CLASS ARE INDEPENDENTLY RELATED TO OUTCOMES IN UNSELECTED OUTPATIENTS WITH HEART FAILURE: INSIGHTS FROM THE STUDY OF ANEMIA IN A HEART FAILURE POPULATION (STAMINA-HFP) REGISTRY (2010) (0)
Refractory heart failure: Optimizing therapy, managing end-stage disease. A guide to making the best use of standard and new treatments (1999) (0)
Mechanistic Efficacy of Sacubitril/Valsartan in Ischemic Versus Nonischemic Heart Failure. (2023) (0)
Acute Kidney Injury: To Be or Not to Be: That Is the Question: It’s the Company It Keeps (2020) (0)
Impaired renal function is common in outpatients with heart failure: results from the STAMINA-HFP (study of anemia in a heart failure population) registry (2003) (0)
tility of Impedance Cardiography or the Identification of Short-Term isk of Clinical Decompensation in table Patients With Chronic Heart Failure (2006) (0)
Abstract 13793: National Survey of Care Processes to Reduce Readmission in Patients Hospitalized for Heart Failure: Factors Associated with Lower Readmission Rates (2011) (0)
PATIENT NAVIGATOR TEAM APPROACH SUCCESSFULLY REDUCES 30-DAY HEART FAILURE (2017) (0)
Nitrate Use And Changes In Functional Status In Black Patients With Chronic Heart Failure With Reduced Ejection Fraction: Insights From The HF-ACTION Trial (2020) (0)
Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America. (2023) (0)
Abstract 117: Decreasing Heart Failure 30 Day Readmission Rate- a Single Center Experience (2012) (0)
PCV61 COST OF EXERCISE TRAINING AND ITS IMPACT ON MEDICAL RESOURCE USE AND COSTS: RESULTS OF HF-ACTION TRIAL (2009) (0)
Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure (2002) (0)
Interdisciplinary Pilot Program to Identify and Reduce 30-Day Heart Failure Readmissions (2016) (0)
Abstract 17396: Effect of Donor Troponin on Heart Transplant Outcomes: A UNOS Registry Analysis (2015) (0)
REAL-WORLD EVALUATION OF PATIROMER TO IMPROVE GUIDELINE-DIRECTED MEDICAL THERAPY IN HEART FAILURE (2020) (0)
173 - Loop Diuretic Change in Patients with Chronic Heart Failure: Insights From HF-ACTION (2017) (0)
P4904Multi-ethnic comparisons of diabetes in heart failure with reduced ejection (2017) (0)
The Heart Failure Home Care (HFHC) Trial : A Multicenter, Randomized, Controlled Trial of a Computer Based Telephonic Heart Failure Monitoring System: Design and Methods (2003) (0)
Improving clinical outcomes and cost-effectiveness in the advanced heart failure patient: A symposium (1998) (0)
ALPHA-2C ADRENERGIC RECEPTOR POLYMORPHISM INTERACTS WITH BETA-BLOCKER DOSE EFFECT ON HEART FAILURE OUTCOMES DIFFERENTLY IN BLACK RACE: RESULTS FROM THE HF-ACTION DNA SUBSTUDY (2015) (0)
NEW PARADIGMS IN HEART FAILURE: RAAS INHIBITION AND THE MANAGEMENT OF HYPERKALAEMIA (2015) (0)
Clinical and Socioeconomic Determinants of Angiotensin Receptor-Neprilysin Inhibitor Prescription at Hospital Discharge in Patients With Heart Failure With Reduced Ejection Fraction (2022) (0)
Greater Pain Severity Is Associated with Worse Outcomes in Patients with Heart Failure (2021) (0)
INTERACTION BETWEEN ST2 LEVELS AND EXERCISE TRAINING IN PATIENTS WITH CHRONIC HEART FAILURE: ANALYSIS FROM THE HF-ACTION TRIAL (2012) (0)
heart Failure Disease Management and Re-hospitalizations in Skilled Nursing Facilities in Cleveland, Ohio. : c125 (2010) (0)
WHY MEASURE NT-PROBNP SERIALLY IN CHRONIC HEART FAILURE? MECHANISTIC ASSOCIATIONS OF NATRIURETIC PEPTIDE SLOPE FOLLOWING INITIATION OF SACUBITRIL/VALSARTAN (2023) (0)
Clinical trials report (2004) (0)
Women and heart failure: a failure of trials? (2005) (0)
Closing the Gap on Sex Disparity in Acute Coronary Syndrome: Is It Time to Reconsider Our Definitions of “Typical”? (2019) (0)
INFLUENCE OF LOW VERSUS HIGH DOSE ON THE ASSOCIATION OF LOOP DIURECTIC AND MORTALITY IN PATIENTS WITH HEART FAILURE: INSIGHTS FROM THE UNITE-HF REGISTRY (2017) (0)
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology. (2022) (0)
Abstract P165: Is Knowledge Given, Knowledge Gained? American Heart Association Heart Failure Protocols and Educational Content within the Intel® Health Guide System (2011) (0)
Association of body surface area with target dose guideline-directed therapy in an international cohort of patients with heart failure (2018) (0)
Iconographies supplémentaires de l'article : Persistence of 123 I- m IBG Prognostic Capability in Relation to Medical Therapy in Heart Failure (from the ADMIRE-HF Trial) (2017) (0)
Abstract 216: Left Ventricular Enlargement and Heart Failure Events: Is Bigger Better? (2012) (0)
Hydralazine/Isosorbide Dinitrate, Blood Pressure and Mortality in Patients with Heart Failure with Reduced Ejection Fraction (2018) (0)
Drug Approval Process for Acute Heart Failure Syndrome in the United States (2008) (0)
PREVALENT DIGOXIN USE IS NOT ASSOCIATED WITH INCREASED RISK OF DEATH OR HOSPITALIZATION IN AMBULATORY HEART FAILURE PATIENTS WITH A REDUCED EJECTION FRACTION (2017) (0)
Decreasing Hemoglobin during Follow-Up Is Associated with Declining Quality of Life in Unselected Outpatients with Heart Failure: Results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry (2006) (0)
Exercise Testing in Congestive Heart Failure Patients (2002) (0)
Fatigue and Exercise Intolerance (2011) (0)
Optimal Medical Therapy in Heart Failure: Reasons for Lack of Medication Titration in the GUIDE IT Trial (2019) (0)
Quality of life assessments predict hospitalization in patients with heart failure (2004) (0)
Performance On Guideline Directed Medical Therapy Remains Low In A Cluster-randomized Trial: Results From CONNECT-HF (2022) (0)
Heart Association Forecasting the Impact of Heart Failure in the United States : A Policy Statement From the Print (2018) (0)
Abstract P230: An Observational Study of Deployment of American Heart Association Heart Failure Protocols and Educational Content Within the Intel® Health Guide System Post Discharge (2011) (0)
Abstract 11886: Effects of Exercise Training on Outcomes in Women with Heart Failure: Analysis of the HF-ACTION Trial by Gender (2012) (0)
Evidence for an Association of Beta Blocker Dose with Outcome in Heart Failure: Insights from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry (2010) (0)
P tility of Impedance Cardiography or the Identification of Short-Term isk of Clinical Decompensation in table Patients With Chronic Heart Failure (2006) (0)
Abstract 2560: Reduction of Filling Pressures During Hospitalization Predicts Sustained Reduction in Heart Failure Symptoms (2006) (0)
Novel Therapeutic Concepts Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction : integrating evidence into clinical practice (2012) (0)
Pulmonary hypertension: an increasingly common challenge for clinicians (2005) (0)
High-Intensity Interval Training Improves Exercise Performance in Patients with LVAD (2018) (0)
044 - Effect of Patiromer on Serum K+ in Hyperkalemic Patients with Heart Failure (HF): Pooled Results From the AMETHYST-DN, OPAL-HK and TOURMALINE Trials (2017) (0)
Abstract 12580: Does Sex Influence the Effect of Surgical Revascularization in Patients in Ischemic Left Ventricular Dysfunction? Results From the STICH Trial (2016) (0)
Consistency Breeds Confidence: The Continuing Story of SGLT2 Inhibitors. (2023) (0)
SACUBITRIL-VALSARTAN FOLLOWING HOSPITAL DISCHARGE FOR HEART FAILURE (2020) (0)
Criteria for use of intravenous milrinone in adult inpatients. (1995) (0)
CARE AND OUTCOMES OF HISPANICS ADMITTED WITH HEART FAILURE WITH PRESERVED AND REDUCED EJECTION FRACTION: FINDINGS FROM GET WITH THE GUIDELINES-HEART FAILURE (2011) (0)
Assessing race and ethnicity differences in outcomes based on GDMT and target NT-proBNP in patients with heart failure with reduced ejection fraction: An analysis of the GUIDE-IT study. (2022) (0)
the Heart Rhythm Society Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Patient Selection for Cardiac Resynchronization Therapy : From the Council on Clinical (2012) (0)
304 - Educational Effectiveness, Participant Demographics, and Practice Patterns Compared to Planned Program Goals of Three Heart Failure Society of America Activities (2017) (0)
Abstract 10790: Association of Beta Blocker Dose with Outcome in Heart Failure is Not Altered by Age: Insights from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry (2010) (0)
Heart Failure Phenotypes According to Natriuretic Peptide Trajectory Following Initiation of Sacubitril/Valsartan. (2023) (0)
Physiology and hemodynamic assessment of the failing heart: Current knowledge and unmet needs for advanced heart failure (2016) (0)
Influence of Neurohormonal Antagonists on the Association of Loop Diuretic Dose with Mortality in Patients with Heart Failure: Insights From the UNITE-HF Registry (2016) (0)
Rationale and Design of the GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study (2014) (0)
Infarction: Results From the NCDR ACTION RegistryGWTG Non-Hispanic Whites Treated for ST-Segment Elevation Myocardial Differences in Treatment Patterns and Outcomes Between Hispanics and (2012) (0)
Outcomes of a Medical Home Model for the Management of COPD and Heart Failure (2010) (0)
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause (2022) (0)
Clinical Decompensation in Stable Patients With Chronic Heart Failure Utility of Impedance Cardiography for the Identification of Short-Term Risk of (2006) (0)
N-terminal Pro-Brain Natriuretic Peptide and Exercise Capacity in Chronic Heart Failure: Data from the HF-ACTION Study (2013) (0)
Risks and benefits of a multidrug approach to mild-to-moderate heart failure. Discussion (2001) (0)
Angiopoetin 2 Predicts Clinical Outcomes And Recovery Of Ventricular Function In Heart Failure (2022) (0)
Abstract 20554: Post-Discharge PharmD Medication Reconciliation and Uptitration Heart Failure Clinic Reduces 30-Day and 90-Day Readmission Rates Compared to Usual Care: An Innovative Approach to the Readmission Dilemma (2014) (0)
Patiromer For The Management Of Hyperkalemia In Patients Receiving Renin-Angiotensin-Aldosterone System Inhibitor Medications For Heart Failure With Reduced Ejection Fraction Has No Difference By Sex: Results From The Diamond Trial (2023) (0)
Health Status Across Major Subgroup of Patients with Heart Failure and Preserved Ejection Fraction. (2023) (0)
One Small Step . . . (2020) (0)
Prognosis and mechanism of death in treated heart failure: data from the placebo arm of Val-HeFT (2003) (0)
STATINS AND EXERCISE TRAINING RESPONSE IN HEART FAILURE PATIENTS: INSIGHTS FROM THE HF-ACTION TRIAL (2015) (0)
Reflecting on the advancements of HFrEF therapies over the last two decades and predicting what is yet to come (2022) (0)
Participating in the Peer Review Process: The Journal of Cardiac Failure Construct. (2022) (0)
Unique populations: different outcomes. (2005) (0)
Abstract P93: Differences in Practice Patterns and Outcomes Between Hispanics and Non-Hispanic Whites Treated for ST-Segment Elevation Myocardial Infarction: Results From ACTION Registry - Get With the Guidelines (2011) (0)
CorrespondenceLetter to the EditorReply (2010) (0)
Need for increased referral of minorities to heart failure clinics (2003) (0)
Abstract 14558: Cardiac Resynchronization Therapy Defibrillators: Pre and Postmarket Experience (2012) (0)
Reversal of ST depression and low maximal oxygen uptake after verapamil with normal coronary arteries and pulmonary disease. (1988) (0)
Abstract 17332: A Multi-Marker Approach for Risk Stratification in Patients With Chronic Heart Failure: Insights From the HF-ACTION Trial (2017) (0)
“Brown Bag Clinic”: A Pharmacist-led Approach to Reduce Heart Failure Hospital Readmission (2021) (0)
Heart Failure in Special Populations (2011) (0)
1069-118 Frequency distribution of hospitalized heart failure patients: Data from the adjudication committee of Val-HeFT (2004) (0)
265 - Establishment of an Institutional Heart Failure Registry as a Cornerstone to Readmission Reduction Efforts (2017) (0)
LONG-TERM ADHERENCE AFTER HOME-MONITORED CARDIAC REHABILITATION (1996) (0)
Atrial Natriuretic Peptide Mediates Reverse Cardiac Remodeling During Treatment with Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction (2020) (0)
Abstract 2505: Predictors of Disability in Activity of Daily Living among Persons with Heart Failure (2006) (0)
A "Silent" Passenger Speaks Loudly. (2020) (0)
The Impact Of Race And Ethnicity On Clinical Outcomes In Patients With Heart Failure(On Behalf Of The Guide-IT Steering Committee) (2022) (0)
Abstract P320: Discordance of Framingham Risk Score and Reynolds Risk Score to Global Vascular Risk Score: Results from the Hispanic Community Health Study/Study of Latinos (2014) (0)
We have journeyed far. (1999) (0)
Physical Activity and Public Health 6-24-2003 Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease : A Statement (2019) (0)
Response to Exercise Training and Outcomes in Patients with Heart Failure and Diabetes Mellitus: Insights from HF-ACTION (2016) (0)
HF-ACTION: Impact on Public Policy, Insurance Reimbursement and Future Clinical Exercise Trials: 6 (2009) (0)
250Effect of patiromer on serum K+ in hyperkalaemic patients with HF: Pooled results from the AMETHYST-DN, OPAL-HK and TOURMALINE trials (2017) (0)
Time to Re-Examine Maternity Leave in Cardiology Training: Proactive Rather Than Reactive. (2022) (0)
Sustained Reduction in Symptoms Related to Reduction of Filling Pressures during Hospitalization for Heart Failure (2006) (0)
CLINICAL CHARACTERISTICS, RESPONSE TO EXERCISE AND OUTCOMES IN HEART FAILURE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: FINDINGS FROM HEART FAILURE – A CONTROLLED TRIAL INVESTIGATING OUTCOMES OF EXERCISE TRAINING (HF-ACTION) (2012) (0)
Evaluation of advanced heart failure shared clinical experience (AHF SCENE) network program (1998) (0)
HIGH CENTER VOLUME IS ASSOCIATED WITH LOWER IN-HOSPITAL MORTALITY IN HEART FAILURE PATIENTS: A NEW YORK STATE WIDE ANALYSIS OF 300,000 ADMISSIONS (2016) (0)
ADJUSTMENT OF GUIDELINE-DIRECTED MEDICAL THERAPY ONE YEAR POST-HEART FAILURE HOSPITALIZATION FALLS SHORT: INSIGHTS FROM THE CONNECT-HF TRIAL (2023) (0)
ADRENERGIC RECEPTOR POLYMORPHISMS INTERACT WITH BETA-BLOCKER DOSE EFFECT ON HEART FAILURE OUTCOMES ESPECIALLY IN BLACK RACE: RESULTS FROM HF-ACTION DNA SUBSTUDY (2015) (0)
Comprar Palliative Nursing: Across the Spectrum of Care | Gary Balady | 9781405169974 | Wiley (2009) (0)
Professionals From the American Heart Association Exercise Standards for Testing and Training: A Statement for Healthcare (2008) (0)
Abstract 13355: Women have Better Survival than Men with Cardiac Resynchronization Therapy in Left Bundle Branch Block: an Observational Comparative Effectiveness Study from the National Cardiovascular Data Registry (2014) (0)
Abstract 16114: Incremental Prognostic Utility by Cost and Complexity in Chronic Heart Failure (2013) (0)
Erratum: The AHF SCENE II preceptorship program: Rationale and design of an education program to optimize management of advanced heart failure (Congestive Heart Failure (2000) 6(6) (319-324)) (2001) (0)
Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Medicine in Ischemic Cardiomyopathy: The STICH Randomized Clinical Trial (2022) (0)
RELATIONSHIP BETWEEN EXERCISE TRAINING AND CHANGES IN BIOMARKERS OF MYOCARDIAL STRESS, INJURY AND INFLAMMATION IN PATIENTS WITH CHRONIC HEART FAILURE (2013) (0)
CO-MORBIDITIES AND ETHNICITY/RACE PREDICT MORBIDITY AND MORTALITY IN HIGH RISK HEART FAILURE PATIENTS WITH SYSTOLIC DYSFUNCTION: THE GUIDE-IT PREDICTIVE RISK MODEL (2018) (0)
The New Kids on the Block: Don't Delay. (2020) (0)
Normalization of Serum Potassium With Sodium Zirconium Cyclosilicate (ZS-9) in Patients With Heart Failure (2015) (0)
Cost of Exercise Training and Its Impact on Medical Resource Use and Costs: Results of HF-ACTION (2009) (0)
Abstract 12023: Relationship of Beta-Blocker (BB) Dose with Outcomes in Ambulatory Heart Failure (HF) Patients with Systolic Dysfunction: Results from the HF-ACTION Trial (2011) (0)
Heart Failure Treatment: A Focus on Treatment in Black Patients (2019) (0)
Corrigendum to ``Increasing Diversity in Clinical Trials: Overcoming Critical Barriers''. [Current Problems in Cardiology, Volume 44, Issue 5 (2019) 148-172]. (2020) (0)
Serial cardiopulmonary exercise testing in cardiac transplant recipients fails to show evidence of reinnervation (1998) (0)
GENDER VARIATION IN THE PREDICTIVE VALIDITY OF THE KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE (2019) (0)
Application to Specific Populations Coronary Artery Disease (2000) (0)
on Physical Activity) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) Atherosclerotic Cardiovascular Disease: A Statement From the Council on Exercise and Physical Activity in the Prevention (2007) (0)
Non-participation in a Heart Failure Clinical Trial: Perspectives and Opportunities from the VICTORIA Trial and Simultaneous Registry (2020) (0)
Investigating Potential Gender-Based Differential Item Functioning for Items in the Kansas City Cardiomyopathy Questionnaire (KCCQ) Physical Limitations Domain (2023) (0)
PCV7 DO MEN AND WOMEN INTERPRET THE KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE (KCCQ) DIFFERENTLY? (2020) (0)
Abstract 3994: Assessment of Heart Failure Therapy Utilization Between Publication of the 2001 and 2005 ACC/AHA Heart Failure Guidelines in a Managed Care Setting (2006) (0)
SAFTY AND PROGNOSTIC VALUE OF EARLY POST INFARCTION EXERCISE TESTING IN AN ELDERLY POPULATION (1985) (0)
Unique populations: different outcomes. (2005) (0)
Differences Between Patients Enrolled Early and Late During Clinical Trial Recruitment: Insights From the HF-ACTION Trial (2018) (0)
SHORT-TERM REPRODUCIBILITY OF CARDIOPULMONARY EXERCISE TEST PARAMETERS IN PATIENTS WITH LEFT VENTRICULAR ASSISTIVE DEVICE (2018) (0)
ASSOCIATION BETWEEN ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITION, CARDIOVASCULAR BIOMARKERS AND CARDIAC REMODELING IN HEART FAILURE WITH REDUCED EJECTION FRACTION (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ileana L. Piña?

Ileana L. Piña is affiliated with the following schools:

Ileana L. Piña's Academic­Influence.com Rankings

Why Is Ileana L. Piña Influential?

Ileana L. Piña's Published Works

Published Works

What Schools Are Affiliated With Ileana L. Piña?

Ileana L. Piña's AcademicInfluence.com Rankings